For example, Kaiser Permanente Northwest Region covers Wegovy as a prescription drug benefit if patients meet the following criteria: Have been diagnosed with chronic weight management Are 18 years or older Have documented their current weight and body mass index (BMI) Are actively following a diet and exercise program Have a BMI of 30 or higher or have a BMI of 27 or higher, plus hypertension, diabetes, or hyperlipidemia Failed a three-month trial or has an allergy, intolerance, or contraindication to phentermine, diethylpropion, Qsymia, and Contrave Failed a three-month trial of Ozempic Medicare doesnt cover medications strictly for weight loss, so Kaiser Medicare Part D plans typically wont cover Wegovy for weight loss alone
M6: \(\beta\)=0.43, 95% CI 0.29, 0.58
And you matter
This algorithm is additionally included in the 2020 ADA Standards of Medical Care in Diabetes and is discussed in additional detail below
Nevertheless, the low or very low certainty of evidence underscores the need for larger population studies with standardized exposure definitions, detailed outcome classification, and comprehensive adjustment for confounding
